Sponsored By

NPA CEO Discusses Regulatory Status of KratomNPA CEO Discusses Regulatory Status of Kratom

In this short video, former FDA official Daniel Fabricant, Ph.D., weighs in on kratom, the popular and controversial botanical.

Josh Long

June 5, 2018

At Natural Products Expo West, we asked the head of the Natural Products Association (NPA)—Daniel Fabricant, Ph.D.—about kratom, a popular and controversial botanical targeted in recent warning letters by his former employer, FDA. Hear what Fabricant had to say about regulatory issues surrounding kratom in the United States, including claims about its ability to help people addicted to opioids.

This is the second in a three-part video series based on a wide-ranging interview with Fabricant at Expo West, which was held in March in Anaheim, California.

About the Author(s)

Josh Long

Associate editorial director, Natural Products Insider, Informa Markets Health and Nutrition

Josh Long has been a journalist since 1997, holds a J.D. from the University of Wyoming College of Law, and was admitted to practice law in Colorado in 2008. Josh is the legal and regulatory editor with Informa's Health and Nutrition Network, specializing on matters related to Natural Products Insider. Ping him with story ideas at [email protected].

Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ members. Yes, it's completely free.

You May Also Like